Vertex Pharmaceuticals, Inc. (VRTX)
425.98
-4.31
(-1.00%)
USD |
NASDAQ |
Apr 27, 16:00
425.98
0.00 (0.00%)
After-Hours: 20:00
Vertex Pharmaceuticals EPS Diluted (Quarterly) : 4.651 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Eli Lilly & Co. | 7.024 |
| Amgen, Inc. | 2.455 |
| Moderna, Inc. | -2.107 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.191B |
| Revenue (Quarterly) | 3.227B |
| Total Expenses (Quarterly) | 2.036B |
| Enterprise Value | 104.73B |
| Gross Profit Margin (Quarterly) | 85.56% |
| Profit Margin (Quarterly) | 36.91% |
| Earnings Yield | 3.60% |
| Operating Earnings Yield | 4.31% |
| Normalized Earnings Yield | 3.938 |